Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.D800019-JLR200 on April 25, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
D800019-JLR200v1
49/8/1855    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Dirbashi, O. Y.
Right arrow Articles by Al-Mokhadab, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Dirbashi, O. Y.
Right arrow Articles by Al-Mokhadab, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 49, 1855-1862, August 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Methods

Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders

Osama Y. Al-Dirbashi1,*,{dagger}, Tomofumi Santa**, Mohamed S. Rashed*, Zuhair Al-Hassnan{dagger}, Nobuyuki Shimozawa{dagger}{dagger}, Aziza Chedrawi§, Minnie Jacob* and Manhal Al-Mokhadab*

* National Laboratory for Newborn Screening, Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 11211 Saudi Arabia
{dagger} Department of Medical Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 11211 Saudi Arabia
§ Department of Neuroscience, King Faisal Specialist Hospital and Research Center, Riyadh 11211 Saudi Arabia
** Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-0033 Japan
{dagger}{dagger} Division of Genomics Research, Life Science Research Center, Gifu University, 1-1 Yanagido, Gifu 501-1193 Japan

This study was funded in part by a grant from Prince Salman Center for Disability Research, Riyadh, Saudi Arabia.

Published, JLR Papers in Press, April 25, 2008.

1 To whom correspondence should be addressed. e-mail: dirbashi{at}kfshrc.edu.sa

Quantification of pristanic acid, phytanic acid, and very long chain fatty acids (i.e., hexacosanoic, tetracosanoic, and docosanoic acids) in plasma is the primary method for investigateing a multitude of peroxisomal disorders (PDs). Typically based on GC-MS, existing methods are time-consuming and laborious. In this paper, we present a rapid and specific liquid chromatography tandem mass spectrometric method based on derivatization with 4-[2-(N,N-dimethylamino)ethylaminosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole (DAABD-AE). Derivatization was undertaken to improve the poor mass spectrometric properties of these fatty acids. Analytes in plasma (20 µl) were hydrolyzed, extracted, and derivatized with DAABD-AE in ~2 h. Derivatives were separated on a reverse-phase column and detected by positive-ion electrospray ionization tandem mass spectrometry with a 5 min injection-to-injection time. Calibration plots were linear over ranges that cover physiological and pathological concentrations. Intraday (n = 12) and interday (n = 10) variations at low and high concentrations were less than 9.2%. Reference intervals in normal plasma (n = 250) were established for each compound and were in agreement with the literature. Using specimens from patients with established diagnosis (n = 20), various PDs were reliably detected. In conclusion, this method allows for the detection of at least nine PDs in a 5 min analytical run. Furthermore, this derivatization approach is potentially applicable to other disease markers carrying the carboxylic group.

Supplementary key words peroxisomes • Zellweger syndrome • DAABD-AE • hexacosanoic acid • tetracosanoic acid • docosanoic acid • derivatization

Abbreviations: DAABD-AE, 4-[2-(N,N-dimethylamino)ethylaminosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole; ESI-MS/MS, electrospray ionization tandem mass spectrometry; IS, internal standard; LC-MS/MS, liquid chromatography tandem mass spectrometry; PBD, peroxisome biogenesis disorder; PD, peroxisomal disorder; PED, single enzyme/transporter deficiency; Phy, phytanic acid; Pri, pristanic acid; QC, quality control; RD, Refsum disease; SRM, selected-reaction monitoring; UPLC, ultra performance liquid chromatography; VLCFA, very long chain fatty acid; X-ALD, X-linked adrenoleukodystrophy; ZS, Zellweger syndrome


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement